I like your thoughts on P11. The only thing I want to add is that somehow (ICT 107) patients with the worse cancer disease from P1 are still living and lived beyond any other known treatment. Something was working! Been long awhile with shares and recent options, believe in the science and think we may have a blockbuster. P11 is make or break with this company IMO.

I totally agree with the safety issue. We are approaching March. What month if you have an idea, based on the longevity of the study, do you think would be positive relative to the release of information. A couple of charts were posted on Yahoo and they seemed to make sense. March would be ok but June/July totally positive. ?? I wonder if we can say the longer the better although makes sense. Maybe we can get some idea from the conferance presentation.

I have shared many of my picks and current positions with my adult children. They are involved and now do there own research. Quite a lesson! One son is doing well with marijuana stocks while the others look at bio techs. They found ISCO on there own and asked me to look at it, then bought it. Same opinion I mentioned to you. We have done well with other bio techs with stock and options. Good luck in your investing!!

Regarding the results, while it is common sense the longer the better, can anyone verify what date would be most appropriate to IMUC. Again, I do financials , while others dictate time frames, etc. The YAHOO board had some postings that made sense regarding beneficial reporting dates. Is there an opinion on this? Thanks.

KarenCA I did notice the revenue stream. In fact my oldest son made a purchase the same day we communicated. Putting the revenue stream aside, the financials are no different than any development co. which is to say, not so good. But, I will be watching the company news and releases. Having a family member invested, I do have an interest. Good luck.

Yeah we have a small correction with IMUC. I guess many trade it. As you know I have been long for some time. Good entry point.

Nice comeback so far. Hope we hold. Have a chance to break thru in the next few trading sessions.

situps- correct on the burn rate of IMUC. Your answer (ISCO).

KarenCA- interesting but financially looks like most early development bio techs (poor balance sheets, etc.). I'll watch it but right now I am all in on IMUC. Good luck!

If we can break thru the next resistance level (2.90 IMO), I think we run to the middle to upper 3's. With good news and some confidence building at the conferance, who knows how high we go. IMUC was oversold and below the 2.10 offering. As well as the stock I have the May 2.50 options which are now in the money. You know the saying "buy on the rumor and sell on the news". That is why I believe a runup is possibly in 2013. Of course bad results, back to where I bought it (.90). Too much volumn for this to be a phony breakout. If we are the real deal, watch out!

They do have a low burn rate. No debt and cash on hand. I agree no secondaries or offerings until year end. By then who knows what price we may be at. This move with volumn is meaningful. If we get to next level, nearing all time high is in sight. Good luck to all.

Do hope so. Maybe sooner.

KarinCA I will look into that.

YH0303, that is nice to hear. Many on the Yahoo board are stating the same. I am a financial anaylst which is not applicable to bio techs in most cases. Financially, IMUC is in good shape i.e. burn rate, cash on hand, no debt, share structure. Also, Yu is renowned and I did research the science. Any info on the predicted analysis is appreciated.

That's my point in securing positive, not necessarily great (although I prefer great) results.

I expect tolerability to the drug based on P1. And I do agree that in the interim that determination would move us up. The presentation will be interesting. Volumn past 3 sessions has been fantastic with IMUC moving up and thru some resistance. Looking good!

I think we are all counting on good results. Even if the results were somewhat less than P1 but life changing for patients, we move up nicely. IMO, I like our chances to succeed!

Based on 51M shares and more than likely up to 60-70M with warrantss, etc. I agree with you. IMUC has got to be a 1B co. with good results. At least $20 per share. However, we could get a nice ride just on anticipation, rumor, etc. Also, what they have to say at the conferance on Monday may give a clue.

Bob, I think 2013 is the year, make or break!

I purchased the May 2.50 strike options as well about a month ago. If we hold, we hit the strike soon. Good results and we skyrocket. Been here long and am a true believer in the science. Time will tell!

Another good start. On our way to 3 if we hold the gains. 50m shares outstanding, no debt, cash on hand, low burn rate, lots to like. Been here awhile and had not sold positions when we touched 4 @ 300% profit. I firmly believe with good results we could approach $20. Good luck to all.

If we can close above 2.28 or so, on our way to high 2's near 3. With excellant news, who knows. I do think something is coming as volumn is too good. Why the volumn just now? Good luck!

Heavy volumn this morning. This follows good volumn last week. Hope this is the beginning to some good news. IMUC generally has more action in the afternoon being a "west coast" company so I see the early action as positive.

Ended the session with real good volumn. It has been quite but hopefully good news soon. Volumn increase a good sign.

Hopefully an update on the safety issue with P11. Results in 2013. New approval for clinical testing. Other drugs in pipeine. We are getting to where we need to be.

Yeah, we have to break thru that level. News would help. At least we are heading in the right direction. The afternoons are generally better for IMUC maybe because it is a west coast company. Patience!

I think so. Volumn is good. Upward trend from the opening. We know news forthcoming and there are no safety issues with the drug. Make or break in 2013. I refused to sell at 4.00 having bought as low as 1.00. In for the long term and do hope I am right about the science.

If we can hold at or about 2.26 we should see a price nearing 3.00. Hopefully some news soon to shoot it up quicker. Looking much better!

I can agree with that number just with minimal success. Double it if even close to P1. Time will tell!

Raj- over $1. ???? I was hoping you meant $10.00.

Nice action today. Good early volumn. Maybe we are close to an announcement.

Real good management. Keeps a lid on O/S. If the science comes thru, not too hard to figure the value with 40-50 million O/S. Minium $25 IMO.

Moving along aren't we! Not blockbuster news but nice to know where we stand.

Right, no slam dunk yet. I limit my investments in bios because off all the uncertainty. That's the gamble. But there are hugh upsides if we have it right.

skit-in agreement! As far as the science, even though P1 is much different and less restricted, I can't imagine a major failure in P11. Must be some reason why those affected are still living. ???. Even a 30% improvement over the standard would propel IMUC. Great partnerships and doctors. I believe in the science and that is why I have been in for some time and refused to sell at 4.00 when my average cost is somewhere just over a 1.00. Hang in there!

Bob- I generally invest the same and IMUC has been long term. Other than equities I like to hold for about a year. I sometimes sell the call option to bring in revenue. So far it has worked prety well.In my younger days always trying to hit a home run. Good luck!

TheStreet.com put out an article on 5 best stocks under $10 for 2013. Imuc included as they are looking for a breakout. Chart looks better. Some news would move us up pretty quick.

I still have a lot of faith. I think 2013 is the year!

bio-bought the May 2.50 strike call options. Have plenty of shares but thought that the options can generate a small score with some good news and updates about P11 and current submissions. I think you are correct that 2013 is IMUC's year, make or break!

Nice seeking alpha article about an hour ago.